Literature DB >> 32508409

Reliability of heterophyid antigens in heterologous protection against human schistosomiasis.

Alaa H A Hegazy1, Lamia A Galal1, Tasneem M Hassan1, Refaat M A Khalifa1.   

Abstract

Schistosomiasis is a neglected tropical parasitic disease which has been controlled by praziquantel for many decades; however, reemergence of praziquantel resistant strains has been a continuous threat. Therefore, the development of reliable antischistosomal vaccine is significantly demanded for optimal control. In the present study, comparison among Schistosoma haematobium, Schsitosoma mansoni and Pygidiopsis genata crude antigens was carried out by Sodium dodecyl sulphate polyacrylamide gel electrophoresis. Hyperimmunization of rabbits with tested parasites' crude antigens was done to obtain hyperimmune sera. Western blotting was applied to show cross reactivity between parasites' crude antigens and either homologous or heterologous sera. Although there was no cross reaction between P. genata crude antigens and sera of both Schistosoma species and vice versa; it is supposed that the immunogenic band at 79 kDa might develop cross reactivity with Schistosma spp. SEA fractionation if used in future studies. © Indian Society for Parasitology 2020.

Entities:  

Keywords:  Heterologous immunity; Pygidiopsis genata; SDS-PAGE; Schistosomiasis; Western blotting

Year:  2020        PMID: 32508409      PMCID: PMC7244675          DOI: 10.1007/s12639-020-01195-8

Source DB:  PubMed          Journal:  J Parasit Dis        ISSN: 0971-7196


  23 in total

1.  SODIUM DODECYL SULPHATE POLYACRILAMIDE GEL ELECTROPHORESIS (SDS-PAGE) FOR DIFFERENTIATION OF DIFFERENT SCHISTOSOME AND FASCIOLID SPECIES.

Authors:  Asmaa M A Elsagheir; Osama H Abd Ellah; Fatma G Sayed; Mohammed E M Monib; Mohammad S Abdel-Kader
Journal:  J Egypt Soc Parasitol       Date:  2015-08

Review 2.  New Anti-Schistosoma Approaches in The People's Republic of China: Development of Diagnostics, Vaccines and Other New Techniques Belonging to the 'Omics' Group.

Authors:  S-B Chen; L Ai; W Hu; J Xu; R Bergquist; Z-Q Qin; J-H Chen
Journal:  Adv Parasitol       Date:  2016-04-05       Impact factor: 3.870

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 5.  Schistosomiasis: a multiplicity of immunopathology.

Authors:  K S Warren
Journal:  J Invest Dermatol       Date:  1976-09       Impact factor: 8.551

6.  Global trends in neglected tropical disease control and elimination: impact on child health.

Authors:  Meagan A Barry; Gregory G Simon; Neeraj Mistry; Peter J Hotez
Journal:  Arch Dis Child       Date:  2013-06-22       Impact factor: 3.791

7.  Induction of protective immunity in cattle against infection with Fasciola hepatica by vaccination with cathepsin L proteinases and with hemoglobin.

Authors:  J P Dalton; S McGonigle; T P Rolph; S J Andrews
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

8.  Use of a partially purified Fasciola gigantica worm antigen in the serological diagnosis of human fascioliasis in Egypt.

Authors:  N S Mansour; F G Youssef; E M Mikhail; F N Boctor
Journal:  Am J Trop Med Hyg       Date:  1983-05       Impact factor: 2.345

9.  Deep sequencing-based identification of pathogen-specific microRNAs in the plasma of rabbits infected with Schistosoma japonicum.

Authors:  Guofeng Cheng; Rong Luo; Chao Hu; Jie Cao; Youxin Jin
Journal:  Parasitology       Date:  2013-08-13       Impact factor: 3.234

10.  Potential Use of Biomphalaria alexandrina Snail Antigens for Serodiagnosis of Schistosomiasis Mansoni by Immunoblot Analysis.

Authors:  Maha Ma Basyoni; Azza Abd El-Wahab
Journal:  Iran J Parasitol       Date:  2013-01       Impact factor: 1.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.